DocuSign, Inc. (NASDAQ:DOCU) Position Increased by Capital Analysts LLC

Capital Analysts LLC boosted its holdings in DocuSign, Inc. (NASDAQ:DOCU) by 781.7% during the 4th quarter, Holdings Channel reports. The fund owned 529 shares of the company’s stock after acquiring an additional 469 shares during the quarter. Capital Analysts LLC’s holdings in DocuSign were worth $31,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in DocuSign by 2.4% in the 3rd quarter. Vanguard Group Inc. now owns 20,982,387 shares of the company’s stock valued at $881,260,000 after acquiring an additional 482,472 shares during the period. Capital World Investors increased its position in DocuSign by 128.3% in the 1st quarter. Capital World Investors now owns 5,683,838 shares of the company’s stock valued at $608,853,000 after acquiring an additional 3,193,727 shares during the period. Morgan Stanley increased its position in DocuSign by 1.7% in the 3rd quarter. Morgan Stanley now owns 3,219,450 shares of the company’s stock valued at $135,217,000 after acquiring an additional 53,553 shares during the period. Clearbridge Investments LLC increased its position in DocuSign by 1.9% in the 1st quarter. Clearbridge Investments LLC now owns 3,186,783 shares of the company’s stock valued at $341,368,000 after acquiring an additional 58,555 shares during the period. Finally, Renaissance Technologies LLC increased its position in DocuSign by 0.3% in the 1st quarter. Renaissance Technologies LLC now owns 2,872,900 shares of the company’s stock valued at $167,490,000 after acquiring an additional 8,300 shares during the period. 77.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Wells Fargo & Company lowered their target price on DocuSign from $55.00 to $45.00 and set an “underweight” rating on the stock in a research report on Monday, February 5th. Needham & Company LLC reiterated a “hold” rating on shares of DocuSign in a research report on Friday, April 12th. Royal Bank of Canada reiterated a “sector perform” rating and set a $59.00 price target on shares of DocuSign in a research report on Friday, April 12th. JMP Securities reiterated a “market outperform” rating and set a $84.00 price target on shares of DocuSign in a research report on Friday, April 12th. Finally, Morgan Stanley upgraded DocuSign from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $49.00 to $64.00 in a research report on Tuesday, January 16th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $60.25.

Insider Transactions at DocuSign

In other news, CEO Allan C. Thygesen sold 7,680 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, CEO Allan C. Thygesen sold 7,680 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the sale, the chief executive officer now owns 111,767 shares of the company’s stock, valued at $6,847,964.09. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Teresa Briggs sold 499 shares of the firm’s stock in a transaction on Thursday, February 29th. The stock was sold at an average price of $52.99, for a total value of $26,442.01. Following the completion of the sale, the director now directly owns 6,169 shares of the company’s stock, valued at approximately $326,895.31. The disclosure for this sale can be found here. Insiders sold a total of 54,871 shares of company stock valued at $3,176,199 over the last quarter. Company insiders own 17.80% of the company’s stock.

DocuSign Stock Down 2.3 %

Shares of NASDAQ DOCU opened at $55.70 on Friday. The stock has a market capitalization of $11.44 billion, a price-to-earnings ratio of 154.73, a PEG ratio of 5.08 and a beta of 0.89. The stock’s fifty day simple moving average is $55.90 and its 200 day simple moving average is $52.12. DocuSign, Inc. has a 52-week low of $38.11 and a 52-week high of $64.76.

DocuSign (NASDAQ:DOCU) last issued its earnings results on Thursday, March 7th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.06. The business had revenue of $712.39 million for the quarter, compared to analysts’ expectations of $698.05 million. DocuSign had a return on equity of 13.91% and a net margin of 2.68%. As a group, analysts anticipate that DocuSign, Inc. will post 0.86 earnings per share for the current year.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.